Blog
882 Articles
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
Let’s Win Lunch and Learn: Pancreatic Cancer and Diabetes
In a special Lunch and Learn webinar, doctors and diabetes educators discuss the relationship between pancreatic cancer and diabetes.
If You Believe You Can Do This . . .
Barry Hendrickson spent much of his career helping cancer patients with hair loss, but he never expected to be in their shoes.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Tomorrow Is a New Day
Abby Pezzulo was an active young working mother when she was diagnosed with a pancreatic neuroendocrine tumor.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Learning to Recognize the Symptoms of Pancreatic Cancer
Recognizing the symptoms of pancreatic cancer is key to early detection. Laura Metzger’s story illustrates the importance of detecting pancreatic cancer early.
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
Let’s Win! Pancreatic Cancer Survivors Series—Year Five
Every year, long-term survivors share their inspiring stories about surviving pancreatic cancer and thriving after.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.